Atlas Trials

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Clinical trial NCT07287592 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07287592
Sponsor
Ain Shams University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
NeuropathyCancer
Start date
2025-12-30
Primary completion
2026-12-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.